May 26, 2016 6:58 PM ET

Biotechnology

Company Overview of Fibrocell Science, Inc.

Executive Profile

Richard G. Azizkhan M.D.

Member of Scientific Advisory Board, Fibrocell Science, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Richard G. Azizkhan, M.D., serves as the Surgeon-in-Chief of the Cincinnati Children's Hospital Medical Center and is the first recipient of the Lester W. Martin Chair in pediatric surgery. Dr. Azizkhan served as the Surgeon-in-Chief and Director of the Pediatric Surgery Training Program at Children's Hospital of Buffalo. Also an avid researcher, he working on a book titled, Operative Pediatric Surgery, He is also acting as the Project Coordinator for Cincinnati ...

Corporate Headquarters

405 Eagleview Boulevard
Exton, Pennsylvania 19341

United States

Phone: 484-713-6000
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD 1975
Penn State Milton S. Hershey Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$450.0K
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$675.0K
Dwayne Montgomery Chief Executive Officer, President and Director
Osiris Therapeutics, Inc.
--
Keith Murphy Chairman, Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer and Member of Science & Technology Committee
Organovo Holdings, Inc.
$469.9K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fibrocell Science, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.